Patents by Inventor Dzung DIEP

Dzung DIEP has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240041976
    Abstract: The invention relates to antibacterial compositions comprising micrococcin P1 and at least one additional antibacterial agent, which is preferably a bacteriocin or an antibiotic. The compositions may be used as an antibacterial, particularly for preventing or treating a bacterial infection.
    Type: Application
    Filed: September 14, 2021
    Publication date: February 8, 2024
    Applicants: Norwegian University of Life Sciences, Norwegian Institute of Bioeconomy Research
    Inventors: Dzung DIEP, Kirill OVCHINNIKOV, Christian KRANJEC, Tage THORSTENSEN
  • Publication number: 20220348615
    Abstract: The present invention relates to the production of bacteriocins, and in particular the production of bacteriocins of class I or II by recombinant expression in coryneform bacteria as the bacterial cell host. Also provided are modified coryneform bacteria for use as production hosts for production of bacteriocins.
    Type: Application
    Filed: April 20, 2022
    Publication date: November 3, 2022
    Applicants: Norwegian University of Science and Technology (NTNU), UNIVERSITÄT ULM, NORWEGIAN UNIVERSITY OF LIFE SCIENCES, DANMARKS TEKNISKE UNIVERSITET, UNIVERSITÄT DES SAARLANDES
    Inventors: Gerd Michael SEIBOLD, Christoph WITTMANN, Dzung DIEP, Nadav BAR, Christian U. REIDEL, Dominik WEIXLER, Oliver GOLDBECK
  • Patent number: 10781236
    Abstract: The present invention provides a multi-peptide composition with antibacterial activity comprising at least 3 peptides with the sequences as set forth in SEQ ID NO:1, 2 or 3 (or related sequences), respectively, in which the SEQ ID NO:1 sequence (or its related sequence) comprises at least two tryptophan residues. In particular the invention provides a new bacteriocin, Garvicin KS. The invention also provides compositions and host cells containing such antibacterial compositions. Uses of the antibacterial composition in treating bacterial infection and products treated with the antibacterial composition are also provided.
    Type: Grant
    Filed: November 11, 2016
    Date of Patent: September 22, 2020
    Assignee: NORWEGIAN UNIVERSITY OF LIFE SCIENCES
    Inventors: Dzung Diep, Ingolf Nes, Ibrahim Mehmeti, Ochinnikov Kiril
  • Publication number: 20180346524
    Abstract: The present invention provides a multi-peptide composition with antibacterial activity comprising at least 3 peptides with the sequences as set forth in SEQ ID NO:1, 2 or 3 (or related sequences), respectively, in which the SEQ ID NO:1 sequence (or its related sequence) comprises at least two tryptophan residues. In particular the invention provides a new bacteriocin, Garvicin KS. The invention also provides compositions and host cells containing such antibacterial compositions. Uses of the antibacterial composition in treating bacterial infection and products treated with the antibacterial composition are also provided.
    Type: Application
    Filed: November 16, 2016
    Publication date: December 6, 2018
    Applicant: NORWEGIAN UNIVERSITY OF LIFE SCIENCES
    Inventors: Dzung DIEP, Ingolf NES, Ibrahim MEHMETI, Ochinnikov KIRIL